The Food and Drug Administration (FDA) reported a shortage of gemifloxacin on 5/27/2015. Gemifloxacin plus azithromycin is an alternative regimen for the treatment of gonorrhea in the presence of cephalosporin allergy. Other alternative regimens are outlined in the 2015 STD Treatment Guidelines.
For more information regarding the availability of gemifloxacin, visit the FDA Drug Shortage Website- http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm#G.
- Page last reviewed: June 5, 2015
- Page last updated: June 5, 2015
- Content source: